Literature DB >> 17015529

Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination.

Joseph F Perz1, Joseph L Elm, Anthony E Fiore, Janice I Huggler, Wendi L Kuhnert, Paul V Effler.   

Abstract

OBJECTIVES: Hawaii implemented routine infant hepatitis B vaccination in 1992 and required it for school entry in 1997. Previously, in 1989, a serologic survey among Hawaii school children in grades 1 to 3 indicated that 1.6% had chronic hepatitis B virus infection, and 2.1% had resolved infection. We conducted a follow-up survey to examine changes in hepatitis B virus infection rates. PATIENTS AND METHODS: This study was performed in Oahu, Hawaii, during the 2001-2002 school year among children in grades 2 and 3. Consenting parents/guardians provided demographic information including place of birth. Participants were tested for serologic evidence of hepatitis B virus infection and their vaccination status was determined by reviewing school records. Rates of symptomatic acute hepatitis B among persons aged < or = 19 years were calculated from cases reported from Hawaii to the Centers for Disease Control and Prevention between 1990 and 2004.
RESULTS: Completed hepatitis B vaccination series were documented for 83% of the 2469 participants by age 18 months and for 97% by age 5 years. Past or present hepatitis B virus infection was detected among 6 participants (0.24%), including 1 (0.04%) with chronic infection and 5 (0.20%) with resolved infections. Compared with the 1989 survey, these prevalences represent declines of 97% and 90% in chronic and resolved hepatitis B virus infections, respectively. The incidence of symptomatic acute hepatitis B in Hawaii children and adolescents aged < or = 19 years decreased from 4.5 cases per 100,000 in 1990 to 0.0 during 2002-2004. To date, the last reported case in a child aged < 15 years in Hawaii occurred in 1996.
CONCLUSIONS: Hepatitis B virus infection has nearly been eliminated in Hawaii children born after universal infant hepatitis B vaccination was implemented. These findings suggest that hepatitis B prevention goals are being met through routine immunization and related prevention programs among US children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015529     DOI: 10.1542/peds.2006-0724

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

Review 1.  Hepatitis B (prevention).

Authors:  Suzanne Norris; Abdul Mohsen
Journal:  BMJ Clin Evid       Date:  2009-09-23

2.  Preventing Hepatitis B-induced Liver Cancer: Implications for Eliminating Health Disparities.

Authors:  Moon S Chen
Journal:  J Health Dispar Res Pract       Date:  2010-10-01

Review 3.  Hepatitis B virus: where do we stand and what is the next step for eradication?

Authors:  Haruki Komatsu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology.

Authors:  Ashish Goyal; John M Murray
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

5.  Long-term T-cell-mediated immunologic memory to hepatitis B vaccine in young adults following neonatal vaccination.

Authors:  Hiva Saffar; Mohammed Jafar Saffar; Abolghasem Ajami; Ali Reza Khalilian; Kian Shams-Esfandabad; Araz Mohammad Mirabi
Journal:  Hepat Mon       Date:  2014-09-23       Impact factor: 0.660

Review 6.  Hepatitis B vaccination and associated oral manifestations: a non-systematic review of literature and case reports.

Authors:  B Tarakji; N Ashok; R Alakeel; Sn Azzeghaibi; A Umair; S Darwish; Rs Mahmoud; E Elkhatat
Journal:  Ann Med Health Sci Res       Date:  2014-11

7.  Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas.

Authors:  Alba Maria Ropero Álvarez; Silvia Pérez-Vilar; Carmelita Pacis-Tirso; Marcela Contreras; Nathalie El Omeiri; Cuauhtémoc Ruiz-Matus; Martha Velandia-González
Journal:  BMC Public Health       Date:  2017-04-17       Impact factor: 3.295

8.  The impact of immigration and vaccination in reducing the incidence of hepatitis B in Catalonia (Spain).

Authors:  Manuel Oviedo; M Pilar Muñoz; Gloria Carmona; Eva Borrás; Joan Batalla; Nuria Soldevila; Angela Domínguez
Journal:  BMC Public Health       Date:  2012-08-06       Impact factor: 3.295

9.  National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.

Authors:  Faruque Ahmed; Joseph F Perz; Sandy Kwong; Patricia M Jamison; Carol Friedman; Beth P Bell
Journal:  Prev Chronic Dis       Date:  2008-06-15       Impact factor: 2.830

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.